Related references
Note: Only part of the references are listed.Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia
Siti Yazmin Zahari Sham et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2022)
MicroRNAs associated with chronic kidney disease in the general population and high-risk subgroups: protocol for a systematic review and meta-analysis
Dipuo Dephney Motshwari et al.
BMJ OPEN (2022)
MicroRNAs as Potential Biomarkers for the Diagnosis of Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Jing Li et al.
FRONTIERS IN MEDICINE (2022)
Urinary IgG, serum CX3CL1 and miRNA-152-3p: as predictors of nephropathy in Egyptian type 2 diabetic patients
Aml E. Abdou et al.
TISSUE BARRIERS (2022)
Resistin, TNF-α, and microRNA 124-3p expressions in peripheral blood mononuclear cells are associated with diabetic nephropathy
Amin Monjezi et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2022)
Analysis of profibrogenic microRNAs (miRNAs) expression in urine and serum of chronic kidney disease (CKD) stage 1-4 patients and their relationship with proteinuria and kidney function
Rafal Donderski et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)
Plasma and urinary extracellular vesicle microRNAs and their related pathways in diabetic kidney disease
Sungjin Park et al.
GENOMICS (2022)
Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study
June Fabian et al.
Lancet Global Health (2022)
Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension
Javier Perez-Hernandez et al.
HYPERTENSION (2021)
Association between circulating microRNAs and changes in kidney function: A five-year prospective study among Japanese adults without CKD
Ryosuke Fujii et al.
CLINICA CHIMICA ACTA (2021)
Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Sara Panizo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy
Yan Hong et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2021)
Involvement of Circulating Exosomal MicroRNAs in Jian-Pi-Yi-Shen Formula Protection Against Adenine-Induced Chronic Kidney Disease
Xinhui Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Dysregulation of miR-638 in diabetic nephropathy and its role in inflammatory response
Mei Lin et al.
DIABETOLOGY & METABOLIC SYNDROME (2021)
Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy
Qiuxia Han et al.
NUTRITION & DIABETES (2021)
Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study
Manoj Khokhar et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2021)
Novel Whole Blood MicroRNAs Predicting Chronic Kidney Disease in South Africans with Hypertension and Diabetes Mellitus
Dipuo D. Motshwari et al.
APPLIED SCIENCES-BASEL (2021)
Circulating let-7g-5p and miR-191-5p Are Independent Predictors of Chronic Kidney Disease in Hypertensive Patients
Olga Berillo et al.
AMERICAN JOURNAL OF HYPERTENSION (2020)
MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells
Jie Su et al.
BIOSCIENCE REPORTS (2020)
Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study
Huiwen Ren et al.
FRONTIERS OF MEDICINE (2020)
The relationship of human tissue microRNAs with those from body fluids
Chunmei Cui et al.
SCIENTIFIC REPORTS (2020)
The correlation of circulating miR-29b and inflammatory markers with albuminuria in hypertensive patients
Cheng Huang et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2020)
Inhibition of miRNA-135a-5p ameliorates TGF-β1-induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy
Juan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
Inflammation, Senescence and MicroRNAs in Chronic Kidney Disease
Andres Carmona et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease
Yanyan Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Identification of a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for chronic kidney disease using next-generation sequencing
Xinying Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
Hiroko Sakuma et al.
FRONTIERS IN PHARMACOLOGY (2020)
MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes
Mohamed Fouad et al.
INDIAN JOURNAL OF NEPHROLOGY (2020)
MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy
Mostafa Abdelsalam et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2020)
Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses
Tais S. Assmann et al.
ACTA DIABETOLOGICA (2019)
MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'
P. Prabu et al.
DIABETES & METABOLISM (2019)
Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations
Justine B. Bukabau et al.
KIDNEY INTERNATIONAL (2019)
MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury
Tim Lange et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy
Jianqin Wang et al.
JOURNAL OF DIABETES RESEARCH (2019)
Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease
Jinnan Zang et al.
SCIENTIFIC REPORTS (2019)
MiR-30e-5p and MiR-15a-5p Expressions in Plasma and Urine of Type 1 Diabetic Patients With Diabetic Kidney Disease
Cristine Dieter et al.
FRONTIERS IN GENETICS (2019)
Diabetic Nephropathy Alters the Distribution of Circulating Angiogenic MicroRNAs Among Extracellular Vesicles, HDL, and Ago-2
Barend W. Florijn et al.
DIABETES (2019)
Correlation Between Serum miR-154-5p and Osteocalcin in Males and Postmenopausal Females of Type 2 Diabetes With Different Urinary Albumin Creatinine Ratios
Huiwen Ren et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa
S. O. Oguntola et al.
BMC NEPHROLOGY (2019)
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy
Francesca Conserva et al.
SCIENTIFIC REPORTS (2019)
Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients
Ligia Petrica et al.
BIOMARKERS IN MEDICINE (2019)
Circulating microRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the Great East Japan Earthquake
Ryosuke Fujii et al.
BMC NEPHROLOGY (2019)
Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease
Bogusz Trojanowicz et al.
NEPHRON (2019)
MicroRNAs and complex diseases: from experimental results to computational models
Xing Chen et al.
BRIEFINGS IN BIOINFORMATICS (2019)
Urinary microRNA in kidney disease: utility and roles
In O. Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
Ophelie Fourdinier et al.
SCIENTIFIC REPORTS (2019)
Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease
Cristina Beltrami et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Universal health coverage and chronic kidney disease in India
Beverley M. Essue et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2018)
Potential serum biomarkers for early detection of diabetic nephropathy
Tarek Kamal Motawi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
The feedback loop between miR-21, PDCD4 and AP-1 functions as a driving force for renal fibrogenesis
Qi Sun et al.
JOURNAL OF CELL SCIENCE (2018)
The association of miR-29a with proteinuria in essential hypertension
Yu-qing Huang et al.
JOURNAL OF HUMAN HYPERTENSION (2018)
MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension
Yong Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension
Javier Perez-Hernandez et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
Kyle J. Foreman et al.
LANCET (2018)
Expression Level of Circulating miR-93 in Serum of Patients with Diabetic Nephropathy
Masoume Akhbari et al.
TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2018)
Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation
Susana Rovira-Llopis et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
MicroRNA profiling in kidney disease: Plasma versus plasma-derived exosomes
Jeffrey X. Xie et al.
GENE (2017)
miR-30e targets GLIPR-2 to modulate diabetic nephropathy: in vitro and in vivo experiments
Dong Zhao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
MicroRNA-92a Mediates Endothelial Dysfunction in CKD
Fenqing Shang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Adeera Levin et al.
LANCET (2017)
Co-expression analysis among microRNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level
Lihua Zhang et al.
METHODS (2017)
Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice
Make Kolling et al.
MOLECULAR THERAPY (2017)
Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients
Khalid Al-Rubeaan et al.
SCIENTIFIC REPORTS (2017)
MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
Jia Guo et al.
SCIENTIFIC REPORTS (2017)
microRNAs in the pathophysiology of CKD-MBD: Biomarkers and innovative drugs
Valerie Metzinger-Le Meuth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease
Ying Shao et al.
ENDOCRINE (2017)
Diabetic nephropathy: serum miR-9 confers a poor prognosis in and is associated with level changes of vascular endothelial growth factor and pigment epithelium-derived factor
Yanxin Xiao et al.
BIOTECHNOLOGY LETTERS (2017)
MicroRNA-155 and Anti-Mullerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney Disease
Dag Eckersten et al.
NEPHRON EXTRA (2017)
Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy
Mariana Cardenas-Gonzalez et al.
CLINICAL CHEMISTRY (2017)
Extracellular microRNA signature in chronic kidney disease
Jagdeesan Muralidharan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation
M. Ulbing et al.
BONE (2017)
miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6
Huaqiang Zhu et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Clinical verification of a novel urinary microRNA panal: 133b,-342 and-30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis
Sanaa Eissa et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Renal microRNA- and RNA-profiles in progressive chronic kidney disease
Michael Rudnicki et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease
Sanaa Eissa et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker
Ghada Al-Kafaji et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy
Yijie Jia et al.
JOURNAL OF DIABETES RESEARCH (2016)
The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio
Xiaoyu Ma et al.
JOURNAL OF DIABETES RESEARCH (2016)
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients
Denis Delic et al.
PLOS ONE (2016)
Biomarker Potential of Urine miR-451 at Different Stages of Diabetic Nephropathy
Emel Isiktas Sayilar et al.
JOURNAL OF DIABETES & METABOLISM (2016)
Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes
Marcus G. Pezzolesi et al.
DIABETES (2015)
Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes
Francesco Prattichizzo et al.
CLINICAL EPIGENETICS (2015)
Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions
Kenneth W. Witwer
CLINICAL CHEMISTRY (2015)
MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1
Feng He et al.
DIABETOLOGIA (2014)
MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
Hai-Yong Chen et al.
MOLECULAR THERAPY (2014)
Assessment of RT-qPCR Normalization Strategies for Accurate Quantification of Extracellular microRNAs in Murine Serum
Thomas C. Roberts et al.
PLOS ONE (2014)
Regulation of Vascular Smooth Muscle Cell Turnover by Endothelial Cell-Secreted MicroRNA-126: Role of Shear Stress
Jing Zhou et al.
CIRCULATION RESEARCH (2013)
A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy
Ji Zhou et al.
GENE (2013)
Decreased MicroRNA Is Involved in the Vascular Remodeling Abnormalities in Chronic Kidney Disease (CKD)
Neal X. Chen et al.
PLOS ONE (2013)
Correction: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
Christos Argyropoulos et al.
PLoS One (2013)
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
Federica Barutta et al.
PLOS ONE (2013)
Urinary miR-29 Correlates with Albuminuria and Carotid Intima-Media Thickness in Type 2 Diabetes Patients
Hui Peng et al.
PLOS ONE (2013)
Pleiotropy of microRNA-192 in the kidney
Robert H. Jenkins et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Ke Zen et al.
MEDICINAL RESEARCH REVIEWS (2012)
Analytical challenges and technical limitations in assessing circulating MiRNAs
Anna Zampetaki et al.
THROMBOSIS AND HAEMOSTASIS (2012)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles
Kirti Bhatt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy
Aleksandra Krupa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MiR-126 regulates angiogenic signaling and vascular integrity
Jason E. Fish et al.
DEVELOPMENTAL CELL (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values
Andrew S. Levey et al.
CLINICAL CHEMISTRY (2007)
Share Paper
